dobutamine has been researched along with pirbuterol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Herold, H; Stroman, F; Szelenyi, I | 1 |
| Acar, J; Le Potier, J; Michel, PL; Sergent, J; Vahanian, A | 1 |
| Ugriumova, MO | 1 |
| Uretsky, BF | 1 |
| Sharpe, DN | 1 |
| Méndez, R | 1 |
| Hutton, I; Rae, AP; Tweddel, AC | 1 |
| Andrews, V; Janicki, JS; Weber, KT | 1 |
| Awan, NA; DeMaria, AN; Evenson, MK; Hermanovich, J; Joye, JA; Mason, DT; Needham, K | 1 |
| Awan, NA; Evenson, MK; Mason, DT; Needham, KE | 1 |
3 review(s) available for dobutamine and pirbuterol
| Article | Year |
|---|---|
[State of the adrenoreceptor system and drug therapy].
Topics: Adrenergic beta-Agonists; Animals; Asthma; Dobutamine; Ethanolamines; Humans; Mice; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Substance Withdrawal Syndrome; Tachyphylaxis | 1985 |
Newer inotropic agents.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Ethanolamines; Heart Failure; Humans; Practolol; Prenalterol; Receptors, Adrenergic, beta | 1984 |
[The old digitalis and the new cardiac inotropic agents].
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardenolides; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Dopamine; Drug Evaluation; Ethanolamines; Humans; Imidazoles | 1983 |
8 other study(ies) available for dobutamine and pirbuterol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence of various adrenergic compounds on plasma potassium levels in conscious dogs and anaesthetized domestic pigs.
Topics: Adrenergic beta-Agonists; Albuterol; Anesthesia; Animals; Dobutamine; Dogs; Drug Interactions; Ethanolamines; Female; Heart Rate; Infusions, Intravenous; Male; Potassium; Swine; Sympathomimetics | 1989 |
[Positive inotropic agents. Generalities and classification].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Ethanolamines; Heart Failure; Heart Ventricles; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Practolol; Prenalterol | 1985 |
Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
Topics: Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Enoximone; Ethanolamines; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Imidazoles | 1986 |
The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Topics: Catecholamines; Dobutamine; Dopamine; Ethanolamines; Heart Failure; Hemodynamics; Humans; Practolol; Prenalterol | 1983 |
Cardiotonic agents in the management of chronic cardiac failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Ethanolamines; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Kidney Function Tests; Male; Middle Aged; Oxygen Consumption | 1982 |
Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Heart Failure; Hemodynamics; Humans; Time Factors; Vasodilator Agents | 1981 |
Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Ethanolamines; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Vascular Resistance | 1981 |